BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1359959)

  • 1. The islet amyloid polypeptide gene and non-insulin-dependent diabetes mellitus in south Indians.
    McCarthy MI; Hitman GA; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
    Diabetes Res Clin Pract; 1992 Oct; 18(1):31-4. PubMed ID: 1359959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction fragment length polymorphisms near the islet amyloid polypeptide gene in Japanese subjects.
    Ohagi S; Ekawa K; Sanke T; Nishi M; Nanjo K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):71-4. PubMed ID: 1362147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-linkage of the islet amyloid polypeptide gene with type 2 (non-insulin-dependent) diabetes mellitus.
    Cook JT; Patel PP; Clark A; Höppener JW; Lips CJ; Mosselman S; O'Rahilly S; Page RC; Wainscoat JS; Turner RC
    Diabetologia; 1991 Feb; 34(2):103-8. PubMed ID: 1676684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of islet amyloid polypeptide.
    Nishi M; Sanke T; Ohagi S; Ekawa K; Wakasaki H; Nanjo K; Bell GI; Steiner DF
    Diabetes Res Clin Pract; 1992 Jan; 15(1):37-44. PubMed ID: 1371737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients.
    Nishi M; Bell GI; Steiner DF
    Diabetologia; 1990 Oct; 33(10):628-30. PubMed ID: 2258001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet amyloid polypeptide gene: no evidence of abnormal promoter region in thirty-five type 2 diabetic patients.
    Tokuyama Y; Kanatsuka A; Suzuki Y; Yamaguchi T; Taira M; Makino H; Yoshida S
    Diabetes Res Clin Pract; 1994 Jan; 22(2-3):99-105. PubMed ID: 8200302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet amyloid polypeptide (IAPP) gene analysis in a Japanese diabetic with marked islet amyloid deposition.
    Kajio H; Kobayashi T; Hara M; Nakanishi K; Sugimoto T; Murase T; Akanuma Y; Kosaka K; Shibasaki Y; Kasuga M
    Diabetes Res Clin Pract; 1992 Jan; 15(1):45-8. PubMed ID: 1541234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet amyloid polypeptide (IAPP) and pancreatic islet amyloid deposition in diabetic and non-diabetic patients.
    Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):3-14. PubMed ID: 1541232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.
    Hanabusa T; Kubo K; Oki C; Nakano Y; Okai K; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 1992 Jan; 15(1):89-96. PubMed ID: 1541240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic islet amyloid formation in patients with noninsulin-dependent diabetes mellitus. Implication for therapeutic strategy.
    Oosterwijk C; Höppener JW; van Hulst KL; Lips CJ
    Int J Pancreatol; 1995 Aug; 18(1):7-14. PubMed ID: 7594773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism in intron 2 of islet amyloid polypeptide gene is associated with lower low-density lipoprotein cholesterol in nondiabetic subjects and in type 2 diabetic patients.
    Rojas I; Gomis R; Casals E; Quintó LI; Franco C; Novials A
    Endocrine; 2002 Nov; 19(2):185-9. PubMed ID: 12588049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes.
    Pildal J; Lajer M; Hansen SK; Almind K; Ambye L; Borch-Johnsen K; Carstensen B; Hansen T; Pedersen O
    Diabet Med; 2003 Jun; 20(6):491-4. PubMed ID: 12786686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
    Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
    Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of insulin treatment on islet amyloid polypeptide (amylin) and insulin gene expression in streptozotocin-induced diabetes in rats.
    Mulder H; Ahrén B; Sundler F
    J Endocrinol; 1997 Mar; 152(3):495-501. PubMed ID: 9071971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet amyloid polypeptide--hen or egg in type 2 diabetes pathogenesis?
    Betsholtz C; Christmanson L; Gebre-Medhin S; Westermark P
    Acta Oncol; 1993; 32(2):149-54. PubMed ID: 8323756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
    Janson J; Soeller WC; Roche PC; Nelson RT; Torchia AJ; Kreutter DK; Butler PC
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7283-8. PubMed ID: 8692984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis.
    Esapa C; Moffitt JH; Novials A; McNamara CM; Levy JC; Laakso M; Gomis R; Clark A
    Biochim Biophys Acta; 2005 Apr; 1740(1):74-8. PubMed ID: 15878744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.
    Verchere CB; D'Alessio DA; Palmiter RD; Weir GC; Bonner-Weir S; Baskin DG; Kahn SE
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3492-6. PubMed ID: 8622964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet amyloid polypeptide (amylin) does not seem to be directly involved in the development of gestational diabetes mellitus.
    Grigorakis SI; Alevizaki M; Rapti E; Anastasiou E; Alevizaki CC; Souvatzoglou A
    Gynecol Obstet Invest; 1997; 44(1):6-10. PubMed ID: 9251946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.